Showing results (11-20 of 874) with videos related to
Sort By:
Pageof 88
Psychopharmacology Bulletin|May 8, 2004
The role of GABA in the pathophysiology and treatment of anxiety disordersCharles B NemeroffHuman Psychopharmacology|October 31, 2002
New directions in the development of antidepressants: the interface of neurobiology and psychiatryCharles B NemeroffBjpsych Open|December 4, 2024
The hypothalamic-pituitary-thyroid axis, depression and risk of suicide: commentary, Luo et alCharles B NemeroffThe Journal of Clinical Psychiatry|July 31, 2007
Prevalence and management of treatment-resistant depressionCharles B NemeroffNeuron|March 4, 2016
Paradise Lost: The Neurobiological and Clinical Consequences of Child Abuse and NeglectCharles B NemeroffThe Journal of Clinical Psychiatry|March 29, 2003
Anxiolytics: past, present, and future agentsCharles B NemeroffThe Journal of Clinical Psychiatry|May 21, 2003
Safety of available agents used to treat bipolar disorder: focus on weight gainCharles B NemeroffThe American Journal of Psychiatry|August 4, 2020
The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?Charles B NemeroffJAMA Psychiatry|March 2, 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersGerard Sanacora, Mark A Frye, William McDonald, et al.Psychopharmacology Bulletin|July 28, 2004
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety DisordersCharles B Nemeroff CBPageof 88